Literature DB >> 21791226

Two cases illustrating successful adjunctive interferon-γ immunotherapy in refractory disseminated coccidioidomycosis.

Christopher A Duplessis1, Drake Tilley, Mary Bavaro, Braden Hale, Steven M Holland.   

Abstract

Protective immunity and host resistance to coccidioidomycosis require a robust cell-mediated immunity with adequate production of Th1 cytokines including interleukin-12, and IFN-γ and appropriate regulation and coordinated functionality of Th1/Th2 responses and IL-12/IFN-γ cytokine axes. IFN-γ augments the anti-fungal activity of effector immune cells against a variety of fungi. Numerous animal models have demonstrated the potential efficacy of adjunctive IFN-γ in treatment of invasive mycoses. Yet, despite these promising data, a paucity of literature documents efficacious adjunctive IFN-γ administration in refractory coccidioidomycosis. We present two cases of refractory disease occurring at our institution who responded to adjunctive IFN-γ. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21791226      PMCID: PMC4103908          DOI: 10.1016/j.jinf.2011.07.006

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  11 in total

Review 1.  Coccidioidomycosis: a review of recent advances.

Authors:  Neil M Ampel
Journal:  Clin Chest Med       Date:  2009-06       Impact factor: 2.878

2.  Interleukin-12 receptor β1 deficiency predisposing to disseminated Coccidioidomycosis.

Authors:  Donald C Vinh; Brian Schwartz; Amy P Hsu; David J Miranda; Patricia A Valdez; Danielle Fink; Karen P Lau; Debra Long-Priel; Douglas B Kuhns; Gulbu Uzel; Stefania Pittaluga; Susan Hoover; John N Galgiani; Steven M Holland
Journal:  Clin Infect Dis       Date:  2011-02-15       Impact factor: 9.079

Review 3.  Defects in the interferon-gamma and interleukin-12 pathways.

Authors:  Sergio D Rosenzweig; Steven M Holland
Journal:  Immunol Rev       Date:  2005-02       Impact factor: 12.988

4.  Clinical features of dominant and recessive interferon gamma receptor 1 deficiencies.

Authors:  Susan E Dorman; Capucine Picard; David Lammas; Klaus Heyne; Jaap T van Dissel; Richard Baretto; Sergio D Rosenzweig; Melanie Newport; Michael Levin; Joachim Roesler; Dinakantha Kumararatne; Jean-Laurent Casanova; Steven M Holland
Journal:  Lancet       Date:  2004 Dec 11-17       Impact factor: 79.321

Review 5.  Coccidioidomycosis: host response and vaccine development.

Authors:  Rebecca A Cox; D Mitchell Magee
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

6.  The spectrum and presentation of disseminated coccidioidomycosis.

Authors:  Rodney D Adam; Sean P Elliott; Mihra S Taljanovic
Journal:  Am J Med       Date:  2009-08       Impact factor: 4.965

7.  Mutation in the signal-transducing chain of the interferon-gamma receptor and susceptibility to mycobacterial infection.

Authors:  S E Dorman; S M Holland
Journal:  J Clin Invest       Date:  1998-06-01       Impact factor: 14.808

Review 8.  Virulence mechanisms of coccidioides.

Authors:  Chiung-Yu Hung; Jianmin Xue; Garry T Cole
Journal:  Ann N Y Acad Sci       Date:  2007-05-18       Impact factor: 5.691

9.  Refractory disseminated coccidioidomycosis and mycobacteriosis in interferon-gamma receptor 1 deficiency.

Authors:  Donald C Vinh; Fares Masannat; Robert B Dzioba; John N Galgiani; Steven M Holland
Journal:  Clin Infect Dis       Date:  2009-09-15       Impact factor: 9.079

10.  Treatment of refractory disseminated nontuberculous mycobacterial infection with interferon gamma. A preliminary report.

Authors:  S M Holland; E M Eisenstein; D B Kuhns; M L Turner; T A Fleisher; W Strober; J I Gallin
Journal:  N Engl J Med       Date:  1994-05-12       Impact factor: 91.245

View more
  11 in total

Review 1.  Cytokines and the regulation of fungus-specific CD4 T cell differentiation.

Authors:  Vanessa Espinosa; Amariliz Rivera
Journal:  Cytokine       Date:  2011-11-30       Impact factor: 3.861

Review 2.  Recent advances in our understanding of the environmental, epidemiological, immunological, and clinical dimensions of coccidioidomycosis.

Authors:  Chinh Nguyen; Bridget Marie Barker; Susan Hoover; David E Nix; Neil M Ampel; Jeffrey A Frelinger; Marc J Orbach; John N Galgiani
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

3.  Card9- and MyD88-Mediated Gamma Interferon and Nitric Oxide Production Is Essential for Resistance to Subcutaneous Coccidioides posadasii Infection.

Authors:  Chiung-Yu Hung; Natalia Castro-Lopez; Garry T Cole
Journal:  Infect Immun       Date:  2016-03-24       Impact factor: 3.441

Review 4.  Adaptive immunity to fungi.

Authors:  Akash Verma; Marcel Wüthrich; George Deepe; Bruce Klein
Journal:  Cold Spring Harb Perspect Med       Date:  2014-11-06       Impact factor: 6.915

5.  Progress Toward a Human Vaccine Against Coccidioidomycosis.

Authors:  Garry T Cole; Brady J Hurtgen; Chiung-Yu Hung
Journal:  Curr Fungal Infect Rep       Date:  2012-12-01

6.  Splenectomy as an effective debulking therapy for disseminated mould infection in acute myeloid leukaemia following adjuvant therapy with interferon gamma and liposomal amphotericin.

Authors:  Anne-Louise Latif; Chrsitina Harper; Ian Macdonald; Anne Morrison
Journal:  Med Mycol Case Rep       Date:  2012-09-10

Review 7.  Central Nervous System Infections Due to Coccidioidomycosis.

Authors:  Niki R Jackson; Janis E Blair; Neil M Ampel
Journal:  J Fungi (Basel)       Date:  2019-06-28

8.  Accelerated Progression of Disseminated Coccidioidomycosis Following SARS-CoV-2 Infection: A Case Report.

Authors:  Daniel S Krauth; Christina M Jamros; Shayna C Rivard; Niels H Olson; Ryan C Maves
Journal:  Mil Med       Date:  2021-04-07       Impact factor: 1.437

Review 9.  Coccidioidomycosis: A Contemporary Review.

Authors:  Nancy F Crum
Journal:  Infect Dis Ther       Date:  2022-03-01

10.  Interferon-γ and voriconazole combined therapy for refractory meningeal coccidioidomycosis in a patient with interferon-γ deficiency.

Authors:  Alejandro De la Hoz; Alexandre Malek; Rodrigo Hasbun
Journal:  IDCases       Date:  2020-05-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.